V. Letscher‐Bru - Concepedia

Author

V. Letscher‐Bru

Institut d’Epidémiologie Neurologique et de Neurologie Tropicale

Also Known As

C Mahinc, J. Waller, L. Marcellin, V Letscher-Bru, V. LETSCHER-BRU, V. Letscher-Bru, V. Letscher‐Bru, Val??rie Letscher-Bru

Publications

1.9K

Citations

H-Index

Concepts

All Affiliations

Institut d’Epidémiologie Neurologique et de Neurologie Tropicale Hôpitaux Universitaires de Strasbourg Inserm Université de Strasbourg Assistance Publique – Hôpitaux de Paris

About

V. Letscher‐Bru is an author at Institut d’Epidémiologie Neurologique et de Neurologie Tropicale specializing in medicine, pathology, and microbiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	737
2	Health Sciences	1	1	56
3	Allergy	1	1	44
4	Cell Biology	1	1	44
5	Immunology	1	1	44

V. Letscher‐Bru

Publications

1.2K

Citations

H-Index

Page 1

	Year	Citations
Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: 10.5-Year Analysis of Susceptibilities of Noncandidal Yeast Species to Fluconazole and Voriconazole Determined by CLSI Standardized Disk Diffusion Testing Michael A. Pfaller, Daniel J. Diekema, David L. Gibbs, Journal of Clinical Microbiology	2008	367
Early diagnosis and monitoring of mucormycosis by detection of circulating DNA in serum: retrospective analysis of 44 cases collected through the French Surveillance Network of Invasive Fungal Infections (RESSIF) Laurence Millon, Raoul Herbrecht, Frédéric Grenouillet, Clinical Microbiology and Infection Early DiagnosisDiagnostic MycologyFrench Surveillance NetworkMedicineDiagnosis	2015	248
Treatment of 21 Cases of Invasive Mucormycosis with Amphotericin B Colloidal Dispersion Raoul Herbrecht, V. Letscher‐Bru, Raleigh A. Bowden, European Journal of Clinical Microbiology & Infectious Diseases MedicineClinical MycologyInvasive MucormycosisDermatology	2001	142
Efficacy of Amphotericin B Lipid Complex in the Treatment of Invasive Fungal Infections in Immunosuppressed Paediatric Patients Raoul Herbrecht, Anne Auvrignon, Emmanuel Andrès, European Journal of Clinical Microbiology & Infectious Diseases Antifungal AgentAntifungal AgentsInvasive Fungal InfectionsMedicineClinical Microbiology	2001	64
Combination of caspofungin and an azole or an amphotericin B formulation in invasive fungal infections Yasmine Nivoix, Alina D. Zamfir, P. Lutun, Journal of Infection Antifungal AgentHealth SciencesAmphotericin B FormulationMedicineMedicinal Fungi	2005	56
Interlaboratory evaluation of Mucorales PCR assays for testing serum specimens: A study by the fungal PCR Initiative and the Modimucor study group Steffi Rocchi, Émeline Scherer, Carlo Mengoli, Medical Mycology	2020	54
Chronic Disseminated<i>Trichosporon asahii</i>Infection in a Leukemic Child Marie-Hélène Meyer, V. Letscher‐Bru, J. Waller, Clinical Infectious Diseases Antifungal AgentParasitic ProtozoaAntifungal AgentsImmunodeficienciesPathogenesis	2002	46
Role of gamma interferon and T cells in congenital <i>Toxoplasma</i> transmission A. Abou‐Bacar, Alexander W. Pfaff, V. Letscher‐Bru, Parasite Immunology ImmunologyPathologyImmunodominanceT CellsImmunotherapy	2004	44
Epidemiological study of invasive pulmonary aspergillosis in a haematology unit by molecular typing of environmental and patient isolates of Aspergillus fumigatus Jean Ménotti, J. Waller, Olivier Meunier, Journal of Hospital Infection Diagnostic MycologyHaematology UnitPathologyMolecular TypingInvasive Pulmonary Aspergillosis	2005	44
Antifungal Activity of Sodium Bicarbonate Against Fungal Agents Causing Superficial Infections V. Letscher‐Bru, C. M. Obszynski, M Samsoen, Mycopathologia Antifungal AgentAntifungal ActivityAntifungal AgentsMedicineMicrobiology	2012	41

Page 1